Stem cell-based therapy for ischemic heart disease

Lien-Cheng Hsiao1, Carolyn Carr, Kuan-Cheng Chang

  • 1Cardiac Metabolism Research Group, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK. lienchenghsiao@gmail.com

Cell Transplantation
|October 10, 2012
PubMed

Insights

Stem cell therapy offers a promising new avenue for treating ischemic heart disease (IHD) and chronic heart failure (HF). Research explores various stem cell types and cardiac tissue engineering for cardiac repair and regeneration.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Stem Cell Biology

Background:

  • Ischemic heart disease (IHD) remains a leading cause of death globally, with chronic heart failure (HF) post-acute myocardial infarction (AMI) posing significant challenges.
  • Current treatments for end-stage HF, like heart transplantation, are limited by donor organ scarcity and the need for lifelong immunosuppression.
  • Stem cell-based cardiac therapy has emerged as a promising regenerative approach for IHD over the past decade.

Purpose of the Study:

  • To review the characteristics of various stem cell types applicable to cardiac repair.
  • To discuss stem cell-based therapeutic strategies for treating IHD.
  • To explore cardiac tissue engineering as an alternative to cell transplantation for improving cell retention and survival.

Main Methods:

  • Review of current literature on stem cell types (bone marrow cells, cardiac stem cells, induced pluripotent stem cells) for cardiac regeneration.
  • Analysis of stem cell-based therapy approaches, including direct cell transplantation and cardiac tissue engineering (CTE).
  • Discussion of the potential benefits and challenges associated with different stem cell sources and therapeutic modalities.

Main Results:

  • Multiple stem cell types, including bone marrow cells (BMCs), cardiac stem cells (CSCs), and induced pluripotent stem cells (iPSCs), show potential for cardiac repair.
  • Stem cell-based therapies, encompassing cell transplantation and cardiac tissue engineering (CTE), are being investigated to address limitations of current HF treatments.
  • CTE presents a potential solution to improve the engraftment and survival rates of transplanted cells in cardiac repair.

Conclusions:

  • Stem cell-based therapy represents a significant advancement in the potential treatment of ischemic heart disease and chronic heart failure.
  • Further research into stem cell characteristics and therapeutic strategies, including CTE, is crucial for clinical translation.
  • Developing effective stem cell therapies could offer a viable alternative to heart transplantation for patients with end-stage heart failure.

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...